|
|
Blood, 1 March 2007, Vol. 109, No. 5, pp. 2198-2201.
Prepublished online as a Blood First Edition Paper on November 2, 2006; DOI 10.1182/blood-2006-08-044008.
Previous Article | Next Article 
Submitted August 25, 2006
Accepted October 23, 2006
Respiratory tract infections and subsequent risk of chronic lymphocytic leukemia
Ola Landgren*, Joshua S Rapkin, Neil E Caporaso, Lene Mellemkjaer, Gloria Gridley, Lynn R Goldin, and Eric A Engels
National Cancer Institute
Danish Cancer Society, Denmark
* Corresponding author; email: landgreo{at}mail.nih.gov.
Recent evidence suggests that chronic lymphocytic leukemia (CLL) might occur following a response to an infectious agent. We conducted a population-based study including 4,249 CLL patients diagnosed in Denmark 1977-1997 and 15,690 frequency matched controls to quantify risk of CLL following various airway infections. Through data linkage we gathered information on hospital inpatient/outpatient discharges listing infections present 1 year prior to CLL. Using logistic regression, we calculated odds ratios (ORs) and 95% confidence intervals (CIs). Personal history of pneumonia was associated with significantly increased CLL risk (OR=1.4;1.2-1.8); risk was restricted to 1-4.99 years prior to CLL diagnosis (OR=1.6;1.2-2.0). Individuals with 3+ prior pneumonia events had a significant 2.5-fold (1.1-5.6) elevated CLL risk, and risk increased with the number of pneumonia episodes (ptrend<0.0001). None of nine other respiratory tract infections was significantly associated with CLL risk. Pneumonia might be a potential CLL trigger, or it could represent pre-malignant immune disruption preceding CLL.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Y. Kristinsson, L. R. Goldin, M. Bjorkholm, J. Koshiol, I. Turesson, and O. Landgren
Genetic and immune-related factors in the pathogenesis of lymphoproliferative and plasma cell malignancies
Haematologica,
November 1, 2009;
94(11):
1581 - 1589.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. R. Goldin, M. Bjorkholm, S. Y. Kristinsson, I. Turesson, and O. Landgren
Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin's lymphomas among relatives of patients with chronic lymphocytic leukemia
Haematologica,
May 1, 2009;
94(5):
647 - 653.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Chiron, C. Pellat-Deceunynck, M. Amiot, R. Bataille, and G. Jego
TLR3 Ligand Induces NF-{kappa}B Activation and Various Fates of Multiple Myeloma Cells Depending on IFN-{alpha} Production
J. Immunol.,
April 1, 2009;
182(7):
4471 - 4478.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Landgren, M. Albitar, W. Ma, F. Abbasi, R. B. Hayes, P. Ghia, G. E. Marti, and N. E. Caporaso
B-Cell Clones as Early Markers for Chronic Lymphocytic Leukemia
N. Engl. J. Med.,
February 12, 2009;
360(7):
659 - 667.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Bekeredjian-Ding, A. Doster, M. Schiller, P. Heyder, H.-M. Lorenz, B. Schraven, U. Bommhardt, and K. Heeg
TLR9-Activating DNA Up-Regulates ZAP70 via Sustained PKB Induction in IgM+ B Cells
J. Immunol.,
December 15, 2008;
181(12):
8267 - 8277.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. C. Chu, R. Catera, K. Hatzi, X.-J. Yan, L. Zhang, X. B. Wang, H. M. Fales, S. L. Allen, J. E. Kolitz, K. R. Rai, et al.
Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA
Blood,
December 15, 2008;
112(13):
5122 - 5129.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Chiron, I. Bekeredjian-Ding, C. Pellat-Deceunynck, R. Bataille, and G. Jego
Toll-like receptors: lessons to learn from normal and malignant human B cells
Blood,
September 15, 2008;
112(6):
2205 - 2213.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Lanemo Myhrinder, E. Hellqvist, E. Sidorova, A. Soderberg, H. Baxendale, C. Dahle, K. Willander, G. Tobin, E. Backman, O. Soderberg, et al.
A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies
Blood,
April 1, 2008;
111(7):
3838 - 3848.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|